US 11958850
Heteroaryl compounds for kinase inhibition
granted A61PA61P1/04A61P1/18
Quick answer
US patent 11958850 (Heteroaryl compounds for kinase inhibition) held by Takeda Pharmaceutical Company Limited expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P1/04, A61P1/18, A61P11/00, A61P15/00